Zalwango Marie Gorreti, Migisha Richard, Agaba Bosco B, Bulage Lilian, Kwesiga Benon, Kadobera Daniel, Ario Alex Riolexus
Uganda Public Health Fellowship Program, Uganda National Institute of Public Health, Kampala, Uganda.
National Malaria Control Division, Ministry of Health, Kampala, Uganda.
Malar J. 2025 Jul 23;24(1):241. doi: 10.1186/s12936-025-05488-2.
In August 2022, an epidemiologic investigation into an outbreak of cases of black water fever, a severe and fatal complication of malaria, was conducted in Kakumiro District, Central Uganda. Findings revealed an association between self-medication and the development of severe malaria complications. Factors associated with self-medication for uncomplicated malaria were described for improved malaria management and prevention of malaria related mortality in Uganda.
A community-based cross-sectional survey was conducted in Kakumiro District in August 2023. Using multistage sampling, 592 households were selected. A semi-structured questionnaire was used to interview one participant per household about self-medication for malaria in a family member of any age who suffered from malaria 6 months prior to the interview. Data on demographics, socio-economic factors, health-seeking behaviour, self-medication and antimalarial storage at home were obtained. Modified Poisson regression model was used for multivariate analysis.
Of the 592 participants interviewed, 368 (62%; 95% CI 58.2-65.9%) had self-medicated for malaria. Self-medication was significantly associated with household heads aged ≥ 35 years (adjusted prevalence ratio [APR]: 1.77; 95% CI 1.04-3.01); distances ≥ 5 km to the health facility (APR: 3.05; 95% CI 2.09-4.47), and storage of antimalarial drugs at home (APR: 2.21; 95% CI 1.36-3.59). Having malaria episodes ≥ 6 in the household within 6 months was protective (APR: 0.39; 95% CI 0.23-0.65). The major reason for self-medication was antimalarial stockouts at health facilities. Drugs used for self-medication were commonly known to 65% of the respondents and were bought from drug shops (75%). Although, 85% used the recommended drug for malaria treatment, the dose was inappropriate for 66% of the patients and despite the under dose, 85% of the patients recovered without hospitalization.
The common occurrence of self-medication for malaria and the high potential for malaria drug resistance and increased malaria mortality due to inappropriate treatment was demonstrated. Adequate antimalarial stock to health facilities, instituting policies prohibiting the sale of incomplete doses by drug shops, social behavioural change campaigns against drug storage in homes and sensitization of communities on the dangers of self-medication and the consumption of inappropriate doses could reduce self-medication practices and its eventual consequences.
2022年8月,在乌干达中部的卡库米罗区对黑水热(疟疾的一种严重且致命的并发症)病例爆发进行了流行病学调查。调查结果显示自我药疗与严重疟疾并发症的发生之间存在关联。描述了与非复杂性疟疾自我药疗相关的因素,以改善乌干达的疟疾管理并预防疟疾相关死亡。
2023年8月在卡库米罗区进行了一项基于社区的横断面调查。采用多阶段抽样,选取了592户家庭。使用半结构化问卷,就访谈前6个月内患有疟疾的任何年龄家庭成员的疟疾自我药疗情况,对每户一名参与者进行访谈。获取了有关人口统计学、社会经济因素、就医行为、自我药疗以及家中抗疟药物储存情况的数据。采用修正泊松回归模型进行多变量分析。
在接受访谈的592名参与者中,368人(62%;95%置信区间58.2 - 65.9%)曾进行疟疾自我药疗。自我药疗与年龄≥35岁的户主(调整患病率比[APR]:1.77;95%置信区间1.04 - 3.01)、距离医疗机构≥5公里(APR:3.05;95%置信区间2.09 - 4.47)以及家中储存抗疟药物(APR:2.21;95%置信区间1.36 - 3.59)显著相关。家庭在6个月内有≥6次疟疾发作具有保护作用(APR:0.39;95%置信区间0.23 - 0.65)。自我药疗的主要原因是医疗机构抗疟药物缺货。65%的受访者知晓用于自我药疗的药物,且这些药物通常从药店购买(75%)。尽管85%的人使用了推荐的疟疾治疗药物,但66%的患者用药剂量不当,且尽管剂量不足,85%的患者未经住院治疗即康复。
证明了疟疾自我药疗的普遍存在以及因治疗不当导致疟疾耐药性和疟疾死亡率增加的高可能性。向医疗机构提供充足的抗疟药物储备,制定政策禁止药店销售不完整剂量的药物,开展反对在家中储存药物的社会行为改变运动,以及提高社区对自我药疗危险和不当剂量用药危害的认识,可减少自我药疗行为及其最终后果。